N. Lozano

First French Pilot Quality Assessment of the EndoPredict Test for Early Luminal Breast Carcinoma.

I. Bièche, P. Lamy, P. de Cremoux, 2018, Anticancer research.

Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: correlation with clinicopathological criteria.

J. Merlin, A. Harlé, P. Génin, 2013, Oncology reports.

PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy

G. Romieu, P. Lamy, F. Dalenc, 2019, Breast Cancer Research and Treatment.

Comparison of Three Real-Time PCR Assays for the Detection of PIK3CA Somatic Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Breast Carcinomas

A. Leroux, J. Salleron, J. Merlin, 2018, Pathology & Oncology Research.

Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.

P. Lamy, F. Bibeau, F. Montels, 2015, The Journal of molecular diagnostics : JMD.

Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study

H. Groen, E. Schuuring, P. Lamy, 2020, Cancers.

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients

H. Groen, E. Schuuring, K. Pantel, 2023, International journal of molecular sciences.

PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy

G. Romieu, P. Lamy, F. Dalenc, 2019, Breast Cancer Research and Treatment.